pharma-company /Medicinal products /Active ingredients

Rx · PZN 04172583

CARBOMEDAC 150 mg concentrate for solution for infusion

German trade nameCARBOMEDAC 150 mg Infusionslösungskonzentrat

Active ingredientCarboplatinPharmaceutical formConcentrate for solution for infusion

Only sporadically available

1.2

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Storage temperature and transport temperature

Extended ambient 0–25 °C

Highest known
purchase price (B2B)

~ €57

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for CARBOMEDAC 150 mg concentrate for solution for infusion.

Review purchasing terms

CARBOMEDAC 150 mg concentrate for solution for infusion contains the active ingredient Carboplatin and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 04172583). The pharma availability index for German wholesale stands at 1.2 out of 10 over the past 30 days – the pack was therefore only sporadically available.

CARBOMEDAC 150 mg concentrate for solution for infusion was only sporadically procurable in the past 30 days. We help you identify additional sources of supply and alternative products.

Request a source of supply

More products containing Carboplatin

NEOCARBO 10 mg/ml concentrate for preparation of a solution for infusion 450 mg/45 ml1.3CARBOMEDAC 450 mg concentrate for solution for infusion0.9CARBO-CELL 150 mg 10 mg/ml solution for infusion0.0CARBO-CELL 450 mg 10 mg/ml solution for infusion0.0CARBO-CELL 50 mg 10 mg/ml solution for infusion0.0
All 45 products containing Carboplatin →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.